Overview

Update
Status
Acquired by on January 7, 2015
Total Equity Funding
$41.46M in 4 Rounds from 6 Investors
Headquarters:
San Francisco, California
Description:
Sequenta is engaged in the discovery and development of clinical diagnostics based on a platform for understanding immune system status.
Founders:
,
Categories:
Biotechnology, Health Diagnostics, Medical
Website:
http://www.sequenta.com/
Social:

Company Details

Update

Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status. A profound revolution in the cost of DNA sequencing has enabled the company to develop brand new approaches to measuring the most variable part of the human genome: the immune cell receptor genes. The incredible diversity created by these genes are at the heart of a large number of conditions critical to human health and disease allowing the company to be in a position to inform a large number of clinical decisions using a single powerful assay.

The company was founded in 2008 by entrepreneurs who previously founded ParaAllele BioScience, a successful startup company sold to Affymetrix in 2005.

Funding Rounds (4) - $41.46M

Update
DateAmount / RoundValuationLead InvestorInvestors
Oct, 2014undisclosed amount / Venture1
Jul, 2013$20M / Series C3
Jan, 2012$8.46M / Venture3
Dec, 2010$13M / Series B4

Current Team (2)

Update

Board Members and Advisors (4)

Update

Offices/Locations (1)

Update
  • HQ

    409 Illinois Street

    San Francisco, California 94158

    United States

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos